Right ventricular failure (RVF) is a common cause of death in patients suffering from pulmonary arterial hypertension (PAH). treatments or bioscaffold alone. Cardiomyocyte hypertrophy and RV fibrosis were both reduced, and von Willebrand factor expression was restored by the MSC-seeded bioscaffold treatment. Overall, our study suggests a potential new regenerative therapy to rescue the pressure-overload… Continue reading Right ventricular failure (RVF) is a common cause of death in patients suffering from pulmonary arterial hypertension (PAH)